Graves’ orbitopathy: lessons from Representational Art

Francesco Trimarchi, Enio Martino, Maria Laura Tanda, Luigi Bartalena

Abstract


Graves’ orbitopathy (GO) is an autoimmune orbital disorder which occurs most commonly in patients with Graves’ disease,  less frequently in patients with chronic autoimmune thyroiditis. Full-blown GO is characterized by exophthalmos, swelling and inflammation of periorbital soft tissues, extraocular muscle dysfunction (responsible for diplopia) and may evolve into  relevant functional and disfiguring sequelae which impair quality of life. GO may very rarely sight-threatening due to optic neuropathy or corneal breakdown. This study reviews a series of  articles dealing with  figurative works of art (sculpture and painting) from the Hellenistic age up to a few years ago, that represent real-life individuals or ideal models with features of GO. Clinical evaluation and a hypothetical ideal treatment is proposed for some selected subjects who appear in the portraits, based on updated clinical and management criteria.

Keywords


Graves’ disease, Graves’orbitopathy, Endo&Art, Exophthalmos, Strabismus

Full Text:

PDF

References


References

1. Smith, T.J., Hegedus, L. (2016) Graves’ disease. N Engl J Med 375(16),1552–1565.

2. Graves, R.J.(1835) Clinical Lectures Newly observed affection of the thyroid gland in females.London Medical and Surgical Journal. 7: 516-517.

3. Parry, C. H. (1825) Disease of the heart., Elements Pathology Therapy 2, 111-118.

4. Bartalena, L., Piantanida, E., Gallo, D., Lai, A., Tanda, M.L. Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy. (2020) Front Endocrinol(Lausanne).2020,11:615993.doi: 10.3389/fendo.2020.615993

5. Taylor,P.N., Zhang, L., Lee, R.W.J., Muller, I., Ezra, D.G., Dayan, C.M., Kahaly, G.J., Ludgate. M. (2020) New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol. Feb;16(2):104-116. doi: 10.1038/s41574-019-0305-4.

6. Bahn, R.S. (2010) Graves' ophthalmopathy. N Engl J Med. Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750..

7. Wiersinga, W.M. (2012) Quality of life in Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab. Jun;26(3):359-70.doi:10.1016/j.beem.2011.11.001. PMID: 22632371.

8. Ponto, K.A., Merkesdal, S., Hommel, G., Pitz, S., Pfeiffer, N., Kahaly, G.J. (2013) Public health relevance of Graves' orbitopathy. J ClinEndocrinolMetab. Jan;98(1):145-52. doi: 10.1210/jc.2012-3119. Epub 2012 Nov 26. PMID: 23185037.

9. Perros, P., Žarković, M.P., Panagiotou, G.C. et al. Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Invest 43, 1717–1722 (2020). https://doi.org/10.1007/s40618-020-01258-w

10. Tanda, M.L., Piantanida, E., Liparulo, L., Veronesi, G., Lai, A., Sassi, L., Pariani, N., Gallo, D., Azzolini, C., Ferrario, M., Bartalena, L. (2013) Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98(4),1443-9. doi: 10.1210/jc.2012-3873

11. Bartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G.J., Marcocci, C., Perros, P., Salvi, M., Wiersinga, W.M; European Group on Graves' Orbitopathy (EUGOGO). .(2016) The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J. 2016 Mar;5(1):9-26.

12. Mourits, M.P., Koornneef, L., Wiersinga, W.M., Prummel, M.F., Berghout, A., van der Gaag, R. (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. Aug;73(8):639-44. doi: 10.1136/bjo.73.8.639.

13. Kahaly, G.J., Riedl, M., König, J., Pitz, S., Ponto, K., Diana, T., Kampmann, E., Kolbe, E., Eckstein, A., Moeller, L.C., Führer, D., Salvi, M., Curro, N., Campi, I., Covelli, D., Leo, M., Marinò, M., Menconi, F., Marcocci, C., Bartalena, L., Perros, P., Wiersinga, W.M.; European Group on Graves' Orbitopathy (EUGOGO). (2018) Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet DiabetesEndocrinol. Apr;6(4):287-298. doi: 10.1016/S2213-8587(18)30020-2.

14. Marketos, S.G., Eftychradis,A.,Koutras,D.A.(1983) The first recognition of the association between goiter and exophthalmos J. Endocrinol. Invest. 6, 401-403.

15. Riva, M.A., Paleari, A., Belingheri, M. (2020) At the origin of “Endocrinology and Art”: Woman’s Head (third century BCE). J Endocrinol Invest43, 1673–1674 https://doi.org/10.1007/s40618-020-01416-0

16. Tassinari, J., Sisti, A. (2016) Exophthalmos (Graves’ orbitopathy) in an ancient sculpture. J Endocrinol Invest39, 1085–1086 https://doi.org/10.1007/s40618-016-0471-3

17. Martino, E., Vitti, P. (2014) Leonardo da Vinci Design of Lady with Graves’ disease (1452–1519). J Endocrinol Invest37, 781 https://doi.org/10.1007/s40618-014-0099-0

18.Di Giacomo, C., Trimarchi, F. (2016) Virgin and Child with Saint Anne by Albrecht Dürer (1471–1528). J Endocrinol Invest39, 355–356). https://doi.org/10.1007/s40618-015-0416-2

19. Trimarchi, F., Di Giacomo, C., Toni, R. (2016) La semeiotica endocrino-metabolica nell’opera del pittore tedesco AlbrechtDürer. L'Endocrinologo17, 45–51. https://doi.org/10.1007/s40619-016-0165-2

20. Dallari, V., Gazzini, L. ,Sacchetto, A. (2021) Was Tiepolo’s wife affected by Graves' disease?JEndocrinol Invest https://doi.org/10.1007/s40618-020-01487-z

21. Di Giacomo, C., Trimarchi, F. ,Bartalena, L. (2017) Maria Carolina of Austria, Queen of Naples and Sicily: a possible case of Graves’ orbitopathy. J Endocrinol Invest40,239–240. https://doi.org/10.1007/s40618-016-0574-x

22. Russo, M., Borzì, G. (2020)The rebel thyroid of a revolutionary First Lady. J Endocrinol Invest43,395–396 https://doi.org/10.1007/s40618-019-01113-7

23. Lazzeri, D., Pozzilli, P. (2018) Exophthalmos or pseudo-exophthalmos in the Last Judgement (1535–1541) by Michelangelo Buonarroti (1475–1564). J Endocrinol Invest. 41, 1485–1486 https://doi.org/10.1007/s40618-018-0962-5

24. Trimarchi, F., Bartalena, L., Arieti, S. et al.(2021)Un case report letterario di tireotossicosi in La coscienza di Zeno di Italo Svevo. L'Endocrinologo.22, 149–155 https://doi.org/10.1007/s40619-021-00846-z

25. Trimarchi, F., Martino,E.,Bartalena, L. (2020) Graves’ orbitopathy represented as feature of a state of mind. J Endocrinol Invest.43, 1343–1344 https://doi.org/10.1007/s40618-020-01250-4

26. Trimarchi, F., Martino, E. ,Bartalena, L. (2021) Comics’ representation of Graves’ orbitopathy, by Emil FerrisJEndocrinol Invest. https://doi.org/10.1007/s40618-020-01469-1

27 Tanda, M.L., Trimarchi, F. (2021) Graves’ orbitopathy in Natalie Frank’soeuvre. J EndocrinolInvest https://doi.org/10.1007/s40618-021-01564-x

28. Accorona, R., Guastella, C.,Pignataro, L. (2020) Mother with child (1921): a Graves’ disease painted by Otto Dix. J Endocrinol Invest. https://doi.org/10.1007/s40618-020-01420-4




DOI: https://doi.org/10.6092/1828-6550/APMB.109.1.2021.SD2

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Trimarchi Francesco, Enio Martino, Maria Laura Tanda, Luigi Bartalena

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.